Paediatric Vaccine Market is expected to increase at 12.2% CAGR during the forecast period 2021-2026

According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016.

Paediatric vaccine market is a billion dollar market accounting for a substantial proportion of healthcare expenditure in the recent times. The paediatric vaccine market is segmented according to indication, technology and vaccine type. According to the indication, the paediatric vaccine market is sub segmented into pneumococcal, DTP, rotavirus, influenza, meningococcal, hepatitis B, Hib, MMR and polio. According to technology the market is further segmented into live or attenuated, inactivated or killed, toxoid, conjugate, subunit and recombinant vaccines. By vaccine type, the global paediatric vaccine market is segmented into monovalent and multivalent vaccines.

A slew of routine immunisation initiatives rolled out by the government and private agencies has broadened the market for the paediatric vaccines. A new wave of funds pumped into the market by different government and private players to cork the rise of the child deaths across the globe has also opened a new window of opportunity for the paediatric vaccine market. As per the report of WHO (World Health Organization), the global spending on immunisation soared from US$21.4 to US$26.9 per infant in 2014. The massive economic boom in some regions of the world is expediting the growth of the paediatric vaccine market.

“To remain ‘ahead’ of your competitors, request for a sample” – https://www.futuremarketinsights.com/reports/sample/rep-gb-1317

Segmentation analysis

  • By indication, pneumococcal segment accounted for higher revenue share in global paediatric vaccines as compared to other product segments. The pneumococcal segment is expected to reach a value of US$ 31.58 Bn by 2026, reflecting a CAGR of 14.4% over the forecast period. The growth of pneumococcal segment is attributed to the increasing incidence of infectious diseases.
  • In terms of revenue, Hib vaccine segment is the second most growing segment and is expected to reach a value of US$ 13.49 Bn by 2026, growing at a CAGR of 13.4%. Hepatitis B and meningococcal segment are expected to show double-digit CAGR growth in the forecast period contributing to the growth of global paediatric vaccine market.
  • By technology, conjugate segment accounted for highest revenue share in global paediatric vaccine market as compared to live or attenuated segment. The conjugate segment is expected to reach a value of US$ 32.09 Bn by 2026, reflecting a CAGR of 14.8% over the forecast period. This is expected to be closely followed by the growth of pneumococcal and meningococcal vaccines in this segment
  • By end user, institutional health centres account for higher demand for paediatric vaccine as compared to other end user segments such as hospital pharmacies and retail pharmacies. The strong growth in institutional health centres can be attributed to increasing government interventions in immunisation programs in order to improve vaccine coverage. Institutional health centres are expected to register highest CAGR of 13.8% over the forecast period.

Regional analysis

By region, North America is dominating the global paediatric vaccine market due to improved healthcare infrastructure in this region. The North America paediatric vaccine market is expected to be valued at US$ 20.15 Bn by 2026 growing at a CAGR for 11.0%. In addition to North America, demand for paediatric vaccines has been significantly growing in Western Europe and APEJ. APEJ is expected to grow at a CAGR for 14.9% over the forecast period and is expected to dominate the market by 2026 by generating revenue of US$ 22.69 Bn and revenues in Western Europe are anticipated to grow by 11.2%. Middle East and Africa is expected to grow at a CAGR of 12.6% and this growth is anticipated by growth government intervention for immunisation by carrying out national level immunisation campaigns and also disease specific immunisation campaigns.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-1317

Key players in the global paediatric vaccine market include

Indian Immunologicals,

GlaaxoSmithKline Plc.,

Pfizer Inc.,

Sanofi, Merck & Co. Inc.,

Panacea Biotec,

Zydus Cadila,

Emergent BioSolutions Inc.,

Serum Institute of India Pvt. Ltd.,

Bharat Biotech.

The growth of paediatric vaccine market is attributed to the development in the research by key players in the field, for instance, in February 2016, GSK submitted US regulatory submission for expanding the indication of FLuLaval Quadrivalent, influenza vaccine, for infants more than 6 months. These developments will boost the growth of the global paediatric vaccine market.

Market Segmentation

Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • MEA
  • Japan

Technology

  • Live or Attenuated Vaccine
  • Inactivated or Killed Vaccine
  • Toxoid Vaccine
  • Conjugate Vaccine
  • Subunit Vaccine
  • Recombinant Vector Vaccine

Indication

  • Pneumococcal Conjugate Vaccine
  • DTP Vaccine
  • Influenza
  • Meningococcal Vaccine
  • Polio Vaccine
  • Rotavirus Vaccine
  • MMR Vaccine
  • Varicella Virus Vaccine

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-1317

End User

  • Hospital Pharmacies
  • Retail Pharmacies
  • Institutional Health Centres

Vaccine Type

  • Monovalent Vaccines
  • Multivalent Vaccines

Lacrimal Duct Stent Tube Market is projected for a promising 6% CAGR during 2021– 2029

Introduction of upgraded and highly precise lacrimal duct stent tube for canalicular stenosis or obstruction and congenital nasolacrimal duct obstruction remains a key booster to the growth of lacrimal duct stent tube market. The global market for lacrimal duct stent tube is projected for a promising 6% CAGR during 2019 – 2029, as suggested by a new Future Market Insights (FMI) report.

There has been higher preference for bicanalicular lacrimal duct stent tube over its monocanalicular counterpart, attributing to the former’s high success rate, suitability for stenting in older patients, and better clinical outcomes. Moreover, increasing prevalence of retina-related conditions, primarily imperforation of nasolacrimal duct, epiphora both in infants and adults, and conditions necessitating dacryocystorhinostomy are other factors responsible for propelling revenue growth of the lacrimal duct stent tube market.

Consistent efforts towards diagnosis and management of lacrimal duct obstruction with enhanced success rate, minimally invasive lacrimal surgery, and better clinical outcomes, and increasing product awareness among ophthalmologist are factors augmenting growth prospects for the lacrimal duct stent tube market.

“To remain ‘ahead’ of your competitors, request for a sample” – https://www.futuremarketinsights.com/reports/sample/rep-gb-9649

Key Takeaways – Lacrimal Duct Stent Tube Market Study

  • Bicanalicular lacrimal duct stent tube is expected to contribute three fourth of revenue share in the lacrimal duct stent tube market owing to its high success rate in stent placement.
  • Hospitals captured maximum share of the lacrimal duct stent tube market owing to highest patient footfall followed by ophthalmic clinics.
  • Attributed to growing patient pool for retinal diseases, especially due to premature births, contributed to the dominance of North America in the lacrimal duct stent tube market.
  • Increasing awareness for availability of the treatment for nasolacrimal duct stent obstruction among caregivers of prematurely born babies and increasing number of skilled professionals are expected to drive growth of the lacrimal duct stent tube market in East Asia.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-9649

Manufacturers Emphasizing Advanced Product Development

Numerous organizations are focusing on new product development for lacrimal duct stent tube. In June 2019, FCI Ophthalmic offered a complete line of BIKA stents namely, BIKA, BIKA for DCR, and Infant BIKA covering a range of sizes that will benefit most of the congenital nasolacrimal duct obstruction (CNLDO) and dacryocystorhinostomy (DCR) cases.

Know More About Lacrimal Duct Stent Tube Market Report

Future Market Insights brings the comprehensive research report on forecast revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each segment from 2014 to 2029. The global lacrimal duct stent tube market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on lacrimal duct stent tube market on basis of product type (monocanalicular lacrimal duct stent tube, bicanalicular lacrimal duct stent tube), and end user (hospitals, ophthalmic clinics, ambulatory surgical centers), across seven major regions.

LACRIMAL DUCT STENT TUBE MARKET TAXONOMY

The global lacrimal duct stent tube is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Product

  • Monocanalicular Lacrimal Duct Stent Tube
  •  Bicanalicular Lacrimal Duct Stent Tube

End User

  • Hospitals
  • Ophthalmic Clinics
  • Ambulatory Surgical Centers

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-9649

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Asia (MEA)

Dental X-ray Systems Market will grow at a striking CAGR of over 6% by the end of 2026

Increasing incidences of acute diseases like cancer has created a robust demand for effective diagnostics and treatment for the early detection of this disease and increase the probability of survival. As a result, dental X-ray systems have witnessed a rapid rise in their demand, on the back of their qualification as a promising diagnostics and treatment procedure. In addition to this, the dental X-ray systems significantly reduce the radiation dose among the patients, which strengthens the trust of the medical practitioners in the equipment and boosts the growth of the dental X-ray systems market.

Rising geriatric population and their edentulous issues directly open lucrative opportunities for the dental X-ray systems market. Moreover, healthcare facilities utilized by the elderly population are subsidized by the government, which in turn, has boosted the usage of dental X-ray systems. According to a report published by Future Market Insights (FMI) opines that the global dental X-ray systems market will grow at a striking CAGR of over 6% by the end of 2026.

With the increasing comfort provided by the portable intraoral X-ray systems, the traditionally used floor mounted dental X-ray systems are gradually becoming obsolete. When weighted on the basis of cost, dental X-ray systems provides far better affordability to the dental clinics and hospitals as compared to the cone-beam computed tomography (CBCT) systems, which is why the sales prospects of the former are better.

“To remain ‘ahead’ of your competitors, request for a sample” – https://www.futuremarketinsights.com/reports/sample/rep-gb-8960

Challenges Pertaining to the Dental X-ray Systems Market: Reduction in Reimbursement

A notable reduction in the primary healthcare facilities for many diseases including oral health will affect the capacity and the resources adversely. Newly formed legislation will enforce reduced reimbursement regulations on the MPFS (Medicare Physician FEE Schedule) and HOPPS (Hospital Outpatient Prospective Payment System), which is expected to cause a drop in the growth of the dental X-ray systems market.

Technological Advancements to Lend Ample Growth Opportunities to the Dental X-ray Systems Market

Innovations and advancements brought about in the medical imaging vicinity and especially, dental X-ray systems have intensified the growth prospects of the dental X-ray systems market. Owing to the progress made by the healthcare industry, there has been a consistent need for the precise diagnosis of the diseases, which has been fulfilled by the dental X-ray systems. Given the multifold applications of these systems, the global dental X-ray systems market is projected to grow exponentially.

North America to Maintain a Strong Hold on the Global Dental X-ray Systems Market

The study on dental X-ray systems market provides a detailed analysis on the basis of several factors affecting the market growth. The key geographies assessed in this study include China, APEC, Europe, Latin America, North America, and Middle East and Africa (MEA). Depending on the market size, North America leads the dental X-ray systems market, attributed to the advanced healthcare facilities and excellent spending capacity. As a subsequence, the regional dental X-ray systems market is expected to bear positive results for the global dental X-ray systems market.

Following the footsteps of North America, Europe is the second most dominating region influencing the growth of the dental X-ray systems market. In addition to this, Asia Pacific is equally estimated to contribute to the growing market size during 2018 – 2026.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-8960

Collaboration and Mergers to Trigger the Growth of the Dental X-ray Systems Market

The report on the dental X-ray systems market includes a comprehensive analysis of the companies devising innovative solutions in the market.

The leading players incorporated in the report are

FONA, J.

MORITA CORP.,

Danaher Corporation,

PLANMECA OY,

Prexion Corporation,

Carestream Dental,

LLC,

Owandy Radiology,

Vatech Co. Ltd.,

The Yoshida Dental Mfg. Co. Ltd.,

Dentsply Sirona,

LED Medical Diagnostics Inc.,

Cefla S.C., and Air Techniques, Inc., among others.

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-8960

Key Segment

Based on the product type

Cephalometric Projections Systems

Portable Intraoral X-ray Systems

Panoramic X-ray Systems

Intraoral X-ray Systems Mounted on the Floor

Based on the geographies

North America

Europe

Latin America

Middle East & Africa (MEA)

China

Medical Nitroglycerin Sprays Market expected to register a CAGR of 4.2% during the forecast period, reaching US$ 147.3 Million by the end of 2030

In a recent study, Future Market Insights (FMI) has forecast the medical nitroglycerin spray market to record consistent growth between 2020 and 2030. The report also projects the market to reach a valuation of US$147.3 Mn by the end of 2030.

Rising prevalence of cardiovascular ailments around the world have led to significant developments in cardiac treatments. Among those, heightening adoption of nitroglycerin sprays is touted as one of the most renowned treatment approaches.

Coronary heart disease is among the leading causes of morbidity and fatality amongst heart patients. This disease is the leading cause of angina pectoris, or acute chest pain, caused due to blockage of arteries. To offset the discomfort, adoption of nitroglycerin sprays is rising significantly.

A significant proportion of the global heart ailment population remain undiagnosed for angina pectoris. According to FMI, this undiagnosed population base is what would possible heighten growth prospects for the market across the upcoming forecast decade.

“To remain ‘ahead’ of your competitors, request for a sample” – https://www.futuremarketinsights.com/reports/sample/rep-gb-12620

Key Takeaways from the Medical Nitroglycerin Sprays Study

North America touted to retain market hegemony, capturing over two-fifths of the revenue share

Prophylaxis of angina pectoris to remain the dominant segment, expanding steadily at 4.1% CAGR from 2020-2030

By distribution channel, online pharmacy sales are poised to witness credible expansion owing to the pandemic and deepening digital literacy

90 metered sprays/bottle dose capacity to remain the most preferred option, registering an index of 1.4

Global medical nitroglycerin sprays market is likely to expand steadily, registering a CAGR of 4.2%

“Continued innovations in product development to roll out effective therapeutic options for angina pectoris treatment characterize vendors’ principal expansion strategies,” concludes the FMI analyst.

COVID-19 Impact Insights

The COVID-19 pandemic has had detrimental impacts on the world at large, bringing in massive revenue shortfalls and reduced profit margins. A long-term economic recession is likely to be perpetuated for the forthcoming years.

With regard to nitroglycerin sprays, the market is expected to decelerate in the professional caregiving sector, attributed to shifting priorities towards the pandemic’s eradication. Therefore, elective surgeries for cardiac diseases are being postponed, leading to limited uptake of nitroglycerin sprays.

This deferment of elective cardiovascular surgeries is prompting patients to opt for homecare alternatives. Consequently, oral and sublingual administration of nitroglycerin sprays has been rising steadily to prevent acute angina attacks.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-12620

Competitive Intelligence

The global medical nitroglycerin sprays market is highly consolidated, with the presence of four prominent players:

Perrigo Company Plc.,

Evus Health Solutions LLC., G.

Pohl-Boskamp GmbH & Co. and

Akrimax Pharmaceuticals LLC.

These players primarily concentrate on portfolio strengthening by introducing new products into the market.

For instance, in September 2020, Perrigo Company Inc. introduced the store brand equivalent of Voltaren® Arthritis Pain Reliever in over-the-counter pharmacy stores. It is the first abbreviated new drug application (ANDA) to receive U.S FDA approval.

In 2006, Evus Health Solutions received clearance from the FDA to launch the NitroMist® Nitroglycerin Lingual Aerosol Spray. The device is a nitrate vasodilator indicated for acute relief of an attack or acute prophylaxis of angina pectoris. This 400 mcg per spray is available in 230 metered or 90 metered sprays per container.

G-Pohl-Boskamp GmbH & Co. is one of Germany’s most successful independent pharmaceutical producers. Its product portfolio includes a range of products for several chronic conditions. In this case, the company manufactures the Nitrolingual Pumpspray available in 60 and 200 metered sprays per container.

More Insights on the Medical Nitroglycerin Sprays Market

Future Market Insights provides an unbiased global industry analysis (2015-2019) and opportunity assessment (2020-2030) on the medical nitroglycerin sprays market. The report provides compelling insights on basis of application (prophylaxis of angina pectoris & acute relief of attack (treatment)), dose capacity (60 metered spray/bottle, 90 metered sprays/bottle, 200 metered sprays/bottle, 230 metered sprays/bottle), and distribution channel (hospital pharmacies, retail pharmacies and online pharmacies) across seven major regions.

Medical Nitroglycerin Sprays Market- Segmental Overview

Application

Prophylaxis of Angina Pectoris

Acute Relief of Attack (Treatment)

Dose Capacity

60 metered sprays/bottle

90 metered sprays/bottle

200 metered sprays/bottle

230 metered sprays/bottle

Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-12620

Region

North America (U.S & Canada)

Latin America (Brazil, Mexico, Argentina & Rest of Latin America)

Europe (Germany, Italy, France, U.K, Spain, BENELUX, Russia & Rest of Europe)

East Asia (China, Japan & South Korea)

South Asia (India, Thailand, Indonesia, Malaysia & Rest of South Asia)

Oceania (Australia & New Zealand)

Middle East & Africa (GCC, South Africa, Northern Africa & Rest of MEA)

Surgical Booms Market Research Report: Overview With Geographical Segmentation By Revenue With Forecast 2029

Surgical booms are also known as Equipment Management Systems (EMS). Surgical booms are used to constrain electrical wiring from the various equipment used in the OR. They also help organise the space in the OR by increasing the working space. Most surgical booms are suspended from the roof of the OR and are available in a number of designs and utilities. According to the latest research by FMI, the global surgical booms market is expected to account for more than US$ 380 Million in terms of value by the end of 2029. The surgical booms market report also projects significant growth potential with an anticipated average Y-o-Y growth rate of over 4.5% during the forecast period.

Increase in the Adoption of Minimally Invasive Surgeries is Likely to Drive the Growth of the Surgical Booms Market

Minimally Invasive Surgery (MIS) is one of the major trends in medicine. MIS is a safe, feasible, and patient-friendly method of performing medical procedures such as surgery. MIS offers reduced postoperative pain, shorter length of stay in a hospital, lesser scarring or damage to tissues, and generally leads to faster recovery. Hence, MIS is easier and less time-consuming. As clinicians seek safer and more efficient ways to perform surgery, they find new applications for minimally invasive procedures, because the benefits of the same for patients are paramount. Furthermore, the increasing number of insurance providers that offer reimbursement for costs incurred during most minimally invasive procedures is expected to increase the adoption rate of minimally invasive surgeries. The Centers for Medicare and Medicaid Services (CMS) provides reimbursement for peripheral access procedures, such as the insertion of a port or catheter into a large central artery that is directly related to or is near the heart. Thus, increase in the number of minimally invasive surgeries is boosting the demand for equipment management systems such as equipment booms.

“To remain ‘ahead’ of your competitors, request for a sample” – https://www.futuremarketinsights.com/reports/sample/rep-gb-4375

High Capital Investment for Integrated OR to Hinder the Growth of Surgical Booms Market

Integrated ORs utilise a crossover of medical interventions to form hybrid technologies. The development and integration of ORs requires the re-organization of professionals. In addition, there is a need to upgrade the capital equipment. Cost of such advanced capital equipment is high. Furthermore, compatibility with existing or new devices/infrastructure is likely to present a hurdle for the designers, manufacturers, and end users of surgical booms. A hybrid OR, on an average, requires 50-80% more space as compared to a conventional OR in the U.S., and 30-40% more in Germany. The additional space required is another factor that is likely to increase the cost of the setup of an integrated OR. Thus, the capital cost required for an integrated OR is likely to hinder the growth of the surgical booms market.

Surgical Booms Market: Segmental Analysis

The global surgical booms market has been segmented on the basis of product, installation, and end user. On the basis of product type, the surgical booms market has been segmented into equipment booms, utility booms, anaesthesia booms, and custom booms. Custom booms lead the market due to the flexibility of choice the customers have from manufacturers. Based on installation, the surgical booms market has been segmented into roof mounting and floor mounting. In terms of revenue, the roof mounting segment is expected to have a major share in the surgical booms market during the forecast period as these are more flexible and conserve space in the OR more effectively. On the basis of end user, the surgical booms market has been categorised into hospitals, ambulatory surgical centres, specialty clinics, and hybrid operating rooms. The revenue generated by the hospitals segment of the surgical booms market is expected to witness significant growth, which is driven by the presence of a large number of ORs and associated ICU departments at various hospitals.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-4375

Surgical Booms Market: Companies

Some of the key players in the surgical booms market include

  • CV Medical LLC.
  • Stryker Corporation
  • Hill Rom Holdings Inc.
  • Amico Group of Companies
  • Steris Plc
  • Ondal Medical Systems GmbH
  • Getinge Group
  • Pratibha Medinox
  • Skytron LLc
  • Palakkad Surgical Industries
  • among others.

SURGICAL BOOMS MARKET TAXONOMY

By Product

  • Equipment Booms
  • Utility Booms
  • Anesthesia Booms
  • Custom Booms

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Hybrid Operating Rooms

By Installation

  • Roof Mounting
  • Floor Mounting

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-4375

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Afric

Understanding COVID-19’s impact on the Robotic Spinal Surgery Market, Infers FMI – 2027

Robotic Spinal Surgery Market Overview

Surgical methods have transformed significantly due to the introduction of the robotic system. One such surgical method is robotic spinal surgery. Spinal surgery is a complex process due to the involvement of the delicate blood vessels and nerves, surrounding the vertebra and can cause serious problems if damaged. Usually, surgeons perform these complex surgeries by implanting the screws in the spinal bones either using their own judgment, or with the help of X-rays taken during the procedure. During this procedure, there is always a significant risk of implanting the screws in the wrong place, or in a suboptimal position. The end result could be paralysis or a less effective surgery. But with the introduction of robotic spinal surgery system surgeons can pre-plan the surgical procedure prior to the actual process and perform a more accurate surgery. The technology can customize procedures according to each patient’s individual anatomy. During the surgery, the physician has to do the real work, but robotic spinal surgery system guides the surgeon’s tools according to the predetermined method to place the implants safely and accurately in the exact pre-planned locations. Robotic spinal surgery system involves the use of robotic arms controlled by surgeons.

“To remain ‘ahead’ of your competitors, request for a sample” – https://www.futuremarketinsights.com/reports/sample/rep-gb-3643

Robotic Spinal Surgery Market: Drivers and Restraints

Hospital cost reduction through decreased length of stay in hospital and aging of the population are the key driving factors for robotic spinal surgery market. Repeatability and reliability associated with the robotic spinal surgery are also making this method of surgery popular among physicians. Rising prevalence of chronic back pain and potential of surgical robots to increase the effectiveness of existing surgical procedures are also the growth driving factors for robotic spinal surgery market.

Robotic Spinal Surgery Market: Region Wise Outlook

Geographically, robotic spinal surgery market is segmented into, North America, Latin America, Eastern Europe, Western Europe, Asia-Pacific excluding Japan, Japan and Middle East & Africa. North Americas region is expected to be biggest market for robotic spinal surgery mainly because of the high standards of surgical procedures and innovation by the key market players. Followed by which is Europe. Asia-Pacific region is expected to be the fastest growing market for the robotic spinal surgery attributed to increasing awareness among physicians and people regarding the treatment of spinal disorder with high accuracy and safety and increasing adoption of robots for surgical procedures by healthcare organizations.

Robotic Spinal Surgery Market: Key Market Participants

  • Mazor Robotics
  • Medtech SA
  • Intuitive Surgical, Inc.
  • Stryker
  • Smith & Nephew
  • NuVasive, Inc., and
  • DePuy Synthes Companies.

These companies are mainly focusing on innovation and acquisition strategies.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-3643

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
  • Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
  • Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, Rest Of MEA)

Robotic Spinal Surgery Market: Segmentation

The global robotic spinal surgery market has been segmented on the basis of application, surgical approach, surgery type, end users, and region.

Based on application global robotic spinal surgery market can be segmented into:

  • Spinal Fusion
  • Laminectomy
  • Disc Replacement
  • Discectomy
  • Foraminotomy

Based on surgical approach global robotic spinal surgery market can be segmented into:

  • Anterior
  • Posterior
  • Lateral

Based on surgery type global robotic spinal surgery market can be segmented into:

  • Open Surgery
  • Minimal Invasive

Based on end users global robotic spinal surgery market can be segmented into:

  • Hospitals
  • Clinics

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-3643

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Transcranial Doppler Devices Market Impacted by COVID-19, to Remain Dormant in Near Term, Projects FMI 2021-2027

Transcranial Doppler Devices Market Overview

Transcranial Doppler is an examination technique uses to measure brain’s blood flow velocity from the basal intracerebral vessels by measuring echoes produced from ultrasound waves which are moving transcranially. A low-frequency transducer nearly of 2 MHz is used to enable sufficient transmission of ultrasound waves through the skull. Transcranial Doppler has an excellent diagnosis accuracies.

Transcranial Doppler is relatively quick and detects arteriovenous malformations, ischemic cerebrovascular disease, sickle cell and cerebral circulatory arrest. Its non-invasive nature and high temporal resolution make it supreme for the study of cerebral hemodynamics. The developed Transcranial Doppler system is an exclusive combination of the certified medical device and research equipment. Technical advancement has led the quick development of portable devices, due to chip integrated circuits containing fast, integrated and low power systems. The impact of such improvements in reforming the global healthcare sector is also recognized as a fundamental factor driving the demand for Transcranial Doppler systems.

“To remain ‘ahead’ of your competitors, request for a sample” – https://www.futuremarketinsights.com/reports/sample/rep-gb-3358

Transcranial Doppler Market: Drivers and Restraints

Variability in age, hematocrit, gender, increase in blood pressure and mental or motor activity disorders, rising awareness of neurodegenerative diseases among a population and has therapeutic potential are the primary drivers for Transcranial Doppler market. Its unique design allows the implementation of the advanced signal processing while keeping the costs low. Transcranial Doppler also used in combination with CT scan, MRI, MRA and carotid duplex ultrasound. Transcranial Doppler technology allows help clinician to gain knowledge about concerned flow characteristics within the insonated vessel and helps in rapid decision making. Poor reimbursement policies and lack of trained professionals are the main challenges for transcranial Doppler market.Systems only built for adults because of the design in which head size is fixed to a narrow range of circumferences excluding to perform check on infants and small children due to their small head size.

B-mode Transcranial color-coded duplex (TCCD) combines pulsed wave Doppler ultrasound identifies the arteries abo ut various anatomic locations with a cross-sectional view of the area of insonation. M-mode display, more advanced technology provides multi-gate flow information and recently Transcranial Doppler market is based on this new technology.

Transcranial Doppler Market: Region-wise Outlook

North America market of Transcranial Doppler dominates the market of other regions. Geography and application classify North America transcranial Doppler market. The primary application of North AmericaTranscranial Doppler market is the diagnosis of sickle cell anemia, emboli detection, and intracranial stenosis.

European and North America region comprises of a vast number of aging population which increases the risk of mental or brain disorders are the primary drivers for the increase in transcranial Doppler market. As per WHO report the economic cost of the neurological disorder in Europe was estimated at 139 million euros, in 2004. In Asia, because of diverse environmental conditions as well as changing lifestyle have led to brain diseases among adults as well as geriatric population. This has created high demand for brain monitoring devices for rapid diagnosis increasing the TCD market. In addition to these factors, government and nongovernment players are investing the huge amount in health care sector.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-3358

Key Players:

  • Cadwell Laboratories , Inc.
  • Natus Medical, Inc.
  • Life Sciences
  • Spiegelberg GmbH & Co. KG
  • Covidien
  • Elekta
  • Rimed Ltd.
  • Atys Medical.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

The regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia-Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • The Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

Transcranial Doppler Devices Market: Segmentation

The global market for Transcranial Doppler systems is segmented by product type, display mode, and end users

By Display Mode

  • M-mode display
  • B-mode display

By Modality

  • Portable
  • Standalone

By End-users

  • Hospitals
  • Specialty clinics
  • Surgical centers

For in-depth competitive analysis Buy Now – https://www.futuremarketinsights.com/checkout/3358

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

3D Bio Printing Market Remains Afloat amid COVID-19 Pandemic, to Surge Positively, Projects FMI 2021– 2030

Academic institutes and hospitals use 3D printing technology to develop various models for training purposes. The technology is increasing used in bio printing where biomaterials such as growth factors and cells are combined with bioink to create tissue-like structures that imitate natural tissues. The global 3D bioprinting market is estimated to surpass US$ 1.2 Bn by 2021, at the market CAGR of 13% during the forecast period (2020-2030), as per a new report by Future Market Insights (FMI).

3D Bioprinting Market – About the Report

[290 Pages Report] Increasing rate of medical device manufacturing across the world has been fuelling the demand for advanced technologies. 3D bioprinting is used to design medical devices. Leading medical device and pharmaceutical manufacturing companies are focusing on improving their product portfolio across the world. The demand in this market is expected to surge in response to the lack of organ donors in adequate number. With research and development (R&D) investment within the medical devices sector poised to rise significantly, the market will gain from increasing growth opportunities in the coming years.

In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving demand for 3D bioprinting. The report tracks the global sales of 3D bioprinting in 20+ high-growth markets, along with analyzing the impact COVID-19 has on the medical device industry in general, and 3D bioprinting in particular. COVID-19 pandemic will show a negative impact on the 3D bioprinting market. Due to short term shut down of production facilities of medical device industries for first few months in 2020

“To remain ‘ahead’ of your competitors, request for a sample” – https://www.futuremarketinsights.com/reports/sample/rep-gb-808

3D bioprinting has immense potential to facilitate organ transplants and drug discovery. 3D printing can copy the actual macro and micro-environment of human organs and tissues which can solve the organ transplant crisis. Advancements in 3D printing technology and its promising applications in the healthcare industry are expected to increase the sale of 3D bioprinting over the forecast period.

As per the report, the technology will find increasing application in orthopedic implants manufacturing. The orthopedic implants segment is in fact forecast to account for over 30% of the market in terms of application.

Key Takeaways from 3D bioprinting Marker Study

  • Exhibiting a little below 13% Y-o-Y growth in 2021, 3D bioprinting market will exhibit solid growth
  • The U.S. will register high demand, accounting for nearly 95% of sales in North America
  • Demand in U.K. is expected to rise significantly, exhibiting above 11% Y-o-Y growth in 2021
  • France and Germany too will register high demand
  • In East Asia, China and Japan are expected to emerge as key market

“Launch of innovative 3D printers and application of 3D bioprinting in tissue engineering and regenerative medicine, medical device manufacturing will augment the growth of global 3D bioprinting market” says the FMI Analyst

Acquisitions, Partnerships and expansion are key Strategic Focus of 3D bioprinting Market Players

Leading players in the 3D bioprinting market on strengthening their market position though the Acquisition, Partnerships and expansion. For Instance,

  • In January 2021, 3D Systems announced its regenerative and bioprinting solutions expansion by actively investing in the regenerative areas, in collaboration with United Therapeutics Corporation.
  • In December 2019, GE Healthcare Life Sciences collaborated with Advanced Solutions Life Sciences (ASLS), a Kentucky-based biotechnology firm, to build an integrated 3D bioprinter by combining their digital advanced technologies.
  • In January 2020, GE Healthcare Life Sciences introduced a new additive manufacturing (AM) facility in Umeå, Sweden that will be dedicated to integrating 3D-printed parts into the company’s production of bio manufacturing equipment. With $2 million in backing, the new center is expected to increase biopharma manufacturers’ access to state-of-the-art technologies

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-808

Who is Winning?

The global market is set to expand its scope in the forecast period, due to rising prevalence of orthopedic disease globally and adoption of 3D bioprinting at various stages of development of orthopedic implants by medical manufacturers. In addition to this, cost effectiveness and increase adaption of 3D bioprinting in dental and regenerative medicine application has augmented the sales of 3D bioprinting.

The key market players covered by FMI include

  • 3D Systems, Inc
  • GE Healthcare (Concept Laser, Arcam AB)
  • EOS GmbH Electro Optical Systems
  • Renishaw plc
  • Stratasys Ltd
  • EnvisionTEC
  • Formlabs, Inc And Organovo Holdings Inc and
  • Advanced Solutions Life Sciences

consolidating their positions through mergers, acquisitions and new product launches.

3D bioprinting Market by Category

Technology

  • Stereolithography (SLA)
  • Selective Laser Sintering
  • Electron Beam Melting
  • Fused Deposition Modeling (FDM)
  • Laminated Object Manufacturing (LOM
  • Inkjet Printing
  • Multi-phase Jet Solidification

Application

  • Surgical Simulation and Training Models
  • Prosthetic Devices
  • Tissue Engineering and Regenerative Medicine
  • Orthopedic Implants
  • Dental Implants
  • Medical Sensors
  • Others

End User

  • Medical Device Manufacturers
  • Pharmaceutical Companies
  • Research & Academic Institutions
  • Contract Research Organizations

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-808

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Middle East and Africa (MEA)
  • Oceania

Digital Radiography Sensor Market 2021 Industry Research, Segmentation, Key Players Analysis and Forecast to 2026

Digital Radiography Sensor Market Overview

Digital radiography in literature and in practice are subcategorized on type of sensors into Computerized Radiography and Digital radiography. Digital radiography based on image conversion are two different types namely- Direct digital radiograph and indirect digital radiograph. Out of many traditional systems available for projecting radiographs, digital radiograph sensors are being used globally. Thus, digital radiography sensor market has taken over other traditional radiograph market since 1990s and the trend is still being followed. In US out of all radiological examinations carried out, radio graphical examination accounts 70% in both children and adults, thus digital radiograph sensors market holds a large market size and share.

Digital Radiography Sensor Market: Drivers and Restraints

Exposure to harmful radiations in patients and radiologists is a major concern in imaging systems. It has been found that use of digital radiography sensors have reduced radiation exposure to about 20 to 80%. This has found to be a major driver in growth of the digital radiography sensor market. More factors influencing digital radiography sensors market such as real time results in case of emergencies, user friendly, low cost of test, less exposure time to radiation, shorter scanning time and readily available portable systems. Digital radiography sensor market is governed by high productivity, elimination of costly films, examination of more patients in less time and superior image quality with less background noise helps provide more accurate results. Digital radiography sensors are popular amongst radiologists and thus indeed driving digital radiography sensor market.

“To remain ‘ahead’ of your competitors, request for a sample” – https://www.futuremarketinsights.com/reports/sample/rep-gb-2276

Digital Radiography Sensor Market: Overview

Present and future of radiography is digital radiography sensor market. Benefits of digital radiography sensor over other imaging systems available have been studied by many radiologists and published by researchers in scientific papers showing tremendous potential for digital radiography sensor market. Since 3 decades traditional computerized radiography market has been extensively replaced with digital radiography sensor market all over the world. This was due to invention of direct digital radiography using charged-couple device in 1990s and many technological advances over the time, hence leading to alarming growth rate of digital radiography sensor market. Initially the sensors were found to be too expensive to be completely replaced but research in technology has been helping hand for digital radiography sensor market. While portable digital radiography has thought to completely replace the CR systems in near future and make immense impact on digital radiography sensor market.

Digital Radiography Sensor Market: Regional Overview

Region wise, the digital radiography sensor market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America dominates digital radiography sensor market globally followed by Europe. Digital radiography sensor market in both America and Europe is driven by the fact of being developed countries, having strong infrastructure for healthcare facilities, awareness and initiative taken by government in use of imaging systems with minimum exposure to harmful radiations and tremendous growth in medical industries, hospitals and research institutes.. In last decade there has been fastest growth of digital radiography sensor market in India, China and rest of the world due to various advancement in technology owing to fast growth in digital radiography sensor market, increase in medical tourism, improvement in healthcare facilities and medical research provided by government. Dental intraoral sensors in digital radiography is expected to be leading hand in digital radiography sensor market growth worldwide, near future.

Digital Radiography Sensor Market: Key Players

  • Hologic, Inc.,
  • Carestream Health Inc.,
  • Canon Inc.,
  • Siemens Healthcare,
  • Philips Healthcare,
  • GE Healthcare,
  • Hitachi Medical Corporation,
  • Fujifilm Medical Systems.
  • Shimadzu Corporation and Toshiba Medical Systems Corporation.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-2276

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
  • Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
  • Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Digital Radiography Sensor Market: Segmentation

The digital radiography sensor market is classified on the basis of product type, taxonomy, technology, end user, modality and geography.

Based on type, the digital radiography sensor market is segmented into the following:

  • Computerized Radiography (CT).
  • Direct Digital Radiography (DDR).

Based on taxonomy, the digital radiography sensor market is segmented into the following:

  • Direct image conversion.
  • Photoconductor- a:Se
  • Indirect image conversion.
  • Scintillator- Csl.
  • Storage Phosphor- BaFBr:Eu2+

Based on technology, the digital radiography sensor market is segmented into the following:

  • Phosphors based image plates – 1980.
  • Amorphous-selenium based image plates – 1987.
  • Slot-scan direct radiography (DR) using Charge-coupled device (CCD) – 1990.
  • Selenium drum DR – 1994.
  • Flat-panel amorphous silicon–cesium iodide scintillator detector – 1995.
  • Flat panel Selenium-based detector – 1995.
  • Gadolinium-based scintillator detector – 1997.
  • Flat-panel Gadolinium-based scintillator, portable detector – 2001.
  • Flat-panel Dynamic detector fluoroscopy in digital subtraction angiography – 2001.
  • Digital tomosynthesis – 2006.
  • Flat-panel Wireless DR detector –

Based on end user, the digital radiography sensor market is segmented into the following:

  • Specialized dental clinics.
  • Diagnostic imaging centre.
  • Research and development centres and companies.
  • Medical centres and universities.

Based modality, the digital radiography sensor market is segmented into the following:

  • Portable
  • Non-portable.

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-2276

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

Bone Marrow Transplant Market 2021 | Scope of Current, Drivers and Restraints, Future Industry 2026

Bone Marrow Transplant Market Overview

Bone marrow transplantation, also referred as hematopoietic stem cell transplantation is the process of replacing diseased or damaged bone marrow or bone marrow stem cells with healthy tissue. Bone marrow is a soft vascular tissue present in the interior of long bones, which is primarily responsible for hematopoiesis (formation of blood cells), production of lymphocytes, and storage of a fat. Bone marrow transplantation procedure is recommended to treat severe stages of leukemia, Hodgkin and non-Hodgkin lymphomas, multiple myeloma, aplastic and sickle cell anemia, thalassemia etc. In 2015, more than 75,000 bone marrow transplants were performed globally and the count is expected to increase by approximately 25% by the end of 2020.

Depending on the source of bone marrow or stem cells, bone marrow transplant procedures are classified as peripheral stem cell transplant (PSCT) or conventional bone marrow transplant. The high potential of the bone marrow transplants and the ongoing researches in the field to reduce the risks and side effects of the procedure will take the market to a new high and provide better healthcare to millions of people in the world.

“To remain ‘ahead’ of your competitors, request for a sample” – https://www.futuremarketinsights.com/reports/sample/rep-gb-1354

Bone Marrow Transplant Market: Drivers and Restraints

Increasing worldwide prevalence of cancers and anemia is the major driver for the growth of global bone marrow transplant market. Moreover, advances in technology, improving healthcare infrastructure, emerging indications of bone marrow transplant for heart and neuronal disorders, growing investment in logistic services, increasing per capita healthcare expenditure are some other factors expected to flourish the global bone marrow transplantation market.

However, tremendous cost of the treatment, scarcity of bone marrow donors and uncertainty of reimbursement in several countries are some major restraints for the growth of global bone marrow transplantation market,

Bone Marrow Transplant Market: Region wise Overview

Geographically, global bone marrow transplant market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. Europe will continue to lead the global bone marrow transplant market due to high density of bone marrow transplant centers and expanding bone marrow registries.

Latin America is anticipated to witness rapid increase in volume of bone marrow transplant market owing to high number of potential candidates for the procedure. Increasing number of bone marrow transplant teams in North America is foreseen to boost the bone marrow transplant market in the region.

Bone Marrow Transplant Market: Key Players

  • Lonza Group Ltd.
  • Merck Millipore Corporation
  • Sanofi-Aventis LLC.
  • AllCells LLC.
  • STEMCELL Technologies
  • ATCC Inc.
  • Hemacare Corporation
  • Cellular Dynamics International
  • ReachBio LLC.
  • Conversant Bio
  • abm Inc.
  • PromoCell GmbH
  • Cruline Human biospecime PRO
  • Lifeline Cell Technology
  • Mesoblast Ltd. and others.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-1354

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
  • Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
  • Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Bone Marrow Transplant Market: Segmentation

The global bone marrow transplant market has been classified on the basis of transplant type, disease indication, end user and geography.

Based on transplant type, the global bone marrow transplant market is divided into following:

  • Autologous Bone Marrow Transplant
  • Allogeneic Bone marrow Transplant

Based on the disease indication, the global bone marrow transplant market is divided into following:

  • Leukemia
  • Lymphoma
  • Myeloma
  • Others (anemia, thalassemia etc.)

Based on the end user type, the global bone marrow transplant market is divided into following:

  • Hospitals
  • Multispecialty Clinics
  • Ambulatory Surgical Centers

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-1354

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint